The global market for Type 2 Diabetes was valued at US$ 77180 million in the year 2024 and is projected to reach a revised size of US$ 137710 million by 2031, growing at a CAGR of 8.8% during the forecast period.

Type 2 Diabetes Market

Type 2 diabetes is a progressive condition in which the body becomes resistant to the normal effects of insulin and/or gradually loses the capacity to produce enough insulin in the pancreas. We do not know what causes type 2 diabetes. Type 2 diabetes is associated with modifiable lifestyle risk factors. Type 2 diabetes also has strong genetic and family related risk factors.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes.

The Type 2 Diabetes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Type 2 Diabetes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Type 2 Diabetes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Type 2 Diabetes Market Report

Report Metric	Details
Report Name	Type 2 Diabetes Market
Accounted market size in year	US$ 77180 million
Forecasted market size in 2031	US$ 137710 million
CAGR	8.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Insulins DPP-4 Inhibitors GLP-1 Receptor Agonists SGLT-2 Inhibitors
Segment by Application	Drugstore Hospital Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novo Nordisk, Sanofi, Merck, Eli Lily, AstraZeneca, Astellas Pharma, Daiichi Sankyo, Biocon, Boehringer Ingelheim
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Type 2 Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Type 2 Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Type 2 Diabetes Market growing?

Ans: The Type 2 Diabetes Market witnessing a CAGR of 8.8% during the forecast period 2025-2031.

What is the Type 2 Diabetes Market size in 2031?

Ans: The Type 2 Diabetes Market size in 2031 will be US$ 137710 million.

Who are the main players in the Type 2 Diabetes Market report?

Ans: The main players in the Type 2 Diabetes Market are Novo Nordisk, Sanofi, Merck, Eli Lily, AstraZeneca, Astellas Pharma, Daiichi Sankyo, Biocon, Boehringer Ingelheim

What are the Application segmentation covered in the Type 2 Diabetes Market report?

Ans: The Applications covered in the Type 2 Diabetes Market report are Drugstore, Hospital, Others

What are the Type segmentation covered in the Type 2 Diabetes Market report?

Ans: The Types covered in the Type 2 Diabetes Market report are Insulins, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT-2 Inhibitors

1 Type 2 Diabetes Market Overview

1.1 Product Definition

1.2 Type 2 Diabetes by Type

1.2.1 Global Type 2 Diabetes Market Value Comparison by Type (2024 VS 2031)

1.2.2 Insulins

1.2.3 DPP-4 Inhibitors

1.2.4 GLP-1 Receptor Agonists

1.2.5 SGLT-2 Inhibitors

1.3 Type 2 Diabetes by Application

1.3.1 Global Type 2 Diabetes Market Value by Application (2024 VS 2031)

1.3.2 Drugstore

1.3.3 Hospital

1.3.4 Others

1.4 Global Type 2 Diabetes Market Size Estimates and Forecasts

1.4.1 Global Type 2 Diabetes Revenue 2020-2031

1.4.2 Global Type 2 Diabetes Sales 2020-2031

1.4.3 Global Type 2 Diabetes Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Type 2 Diabetes Market Competition by Manufacturers

2.1 Global Type 2 Diabetes Sales Market Share by Manufacturers (2020-2025)

2.2 Global Type 2 Diabetes Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Type 2 Diabetes Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Type 2 Diabetes, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Type 2 Diabetes, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Type 2 Diabetes, Product Type & Application

2.7 Global Key Manufacturers of Type 2 Diabetes, Date of Enter into This Industry

2.8 Global Type 2 Diabetes Market Competitive Situation and Trends

2.8.1 Global Type 2 Diabetes Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Type 2 Diabetes Players Market Share by Revenue

2.8.3 Global Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Type 2 Diabetes Market Scenario by Region

3.1 Global Type 2 Diabetes Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Type 2 Diabetes Sales by Region: 2020-2031

3.2.1 Global Type 2 Diabetes Sales by Region: 2020-2025

3.2.2 Global Type 2 Diabetes Sales by Region: 2026-2031

3.3 Global Type 2 Diabetes Revenue by Region: 2020-2031

3.3.1 Global Type 2 Diabetes Revenue by Region: 2020-2025

3.3.2 Global Type 2 Diabetes Revenue by Region: 2026-2031

3.4 North America Type 2 Diabetes Market Facts & Figures by Country

3.4.1 North America Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Type 2 Diabetes Sales by Country (2020-2031)

3.4.3 North America Type 2 Diabetes Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Type 2 Diabetes Market Facts & Figures by Country

3.5.1 Europe Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Type 2 Diabetes Sales by Country (2020-2031)

3.5.3 Europe Type 2 Diabetes Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Type 2 Diabetes Market Facts & Figures by Region

3.6.1 Asia Pacific Type 2 Diabetes Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Type 2 Diabetes Sales by Region (2020-2031)

3.6.3 Asia Pacific Type 2 Diabetes Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Type 2 Diabetes Market Facts & Figures by Country

3.7.1 Latin America Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Type 2 Diabetes Sales by Country (2020-2031)

3.7.3 Latin America Type 2 Diabetes Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Type 2 Diabetes Market Facts & Figures by Country

3.8.1 Middle East and Africa Type 2 Diabetes Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Type 2 Diabetes Sales by Country (2020-2031)

3.8.3 Middle East and Africa Type 2 Diabetes Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Type 2 Diabetes Sales by Type (2020-2031)

4.1.1 Global Type 2 Diabetes Sales by Type (2020-2025)

4.1.2 Global Type 2 Diabetes Sales by Type (2026-2031)

4.1.3 Global Type 2 Diabetes Sales Market Share by Type (2020-2031)

4.2 Global Type 2 Diabetes Revenue by Type (2020-2031)

4.2.1 Global Type 2 Diabetes Revenue by Type (2020-2025)

4.2.2 Global Type 2 Diabetes Revenue by Type (2026-2031)

4.2.3 Global Type 2 Diabetes Revenue Market Share by Type (2020-2031)

4.3 Global Type 2 Diabetes Price by Type (2020-2031)

5 Segment by Application

5.1 Global Type 2 Diabetes Sales by Application (2020-2031)

5.1.1 Global Type 2 Diabetes Sales by Application (2020-2025)

5.1.2 Global Type 2 Diabetes Sales by Application (2026-2031)

5.1.3 Global Type 2 Diabetes Sales Market Share by Application (2020-2031)

5.2 Global Type 2 Diabetes Revenue by Application (2020-2031)

5.2.1 Global Type 2 Diabetes Revenue by Application (2020-2025)

5.2.2 Global Type 2 Diabetes Revenue by Application (2026-2031)

5.2.3 Global Type 2 Diabetes Revenue Market Share by Application (2020-2031)

5.3 Global Type 2 Diabetes Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Novo Nordisk

6.1.1 Novo Nordisk Company Information

6.1.2 Novo Nordisk Description and Business Overview

6.1.3 Novo Nordisk Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Novo Nordisk Type 2 Diabetes Product Portfolio

6.1.5 Novo Nordisk Recent Developments/Updates

6.2 Sanofi

6.2.1 Sanofi Company Information

6.2.2 Sanofi Description and Business Overview

6.2.3 Sanofi Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Sanofi Type 2 Diabetes Product Portfolio

6.2.5 Sanofi Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merck Type 2 Diabetes Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Eli Lily

6.4.1 Eli Lily Company Information

6.4.2 Eli Lily Description and Business Overview

6.4.3 Eli Lily Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Eli Lily Type 2 Diabetes Product Portfolio

6.4.5 Eli Lily Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.5.4 AstraZeneca Type 2 Diabetes Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Astellas Pharma

6.6.1 Astellas Pharma Company Information

6.6.2 Astellas Pharma Description and Business Overview

6.6.3 Astellas Pharma Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Astellas Pharma Type 2 Diabetes Product Portfolio

6.6.5 Astellas Pharma Recent Developments/Updates

6.7 Daiichi Sankyo

6.7.1 Daiichi Sankyo Company Information

6.7.2 Daiichi Sankyo Description and Business Overview

6.7.3 Daiichi Sankyo Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Daiichi Sankyo Type 2 Diabetes Product Portfolio

6.7.5 Daiichi Sankyo Recent Developments/Updates

6.8 Biocon

6.8.1 Biocon Company Information

6.8.2 Biocon Description and Business Overview

6.8.3 Biocon Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Biocon Type 2 Diabetes Product Portfolio

6.8.5 Biocon Recent Developments/Updates

6.9 Boehringer Ingelheim

6.9.1 Boehringer Ingelheim Company Information

6.9.2 Boehringer Ingelheim Description and Business Overview

6.9.3 Boehringer Ingelheim Type 2 Diabetes Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Boehringer Ingelheim Type 2 Diabetes Product Portfolio

6.9.5 Boehringer Ingelheim Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Type 2 Diabetes Industry Chain Analysis

7.2 Type 2 Diabetes Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Type 2 Diabetes Production Mode & Process Analysis

7.4 Type 2 Diabetes Sales and Marketing

7.4.1 Type 2 Diabetes Sales Channels

7.4.2 Type 2 Diabetes Distributors

7.5 Type 2 Diabetes Customer Analysis

8 Type 2 Diabetes Market Dynamics

8.1 Type 2 Diabetes Industry Trends

8.2 Type 2 Diabetes Market Drivers

8.3 Type 2 Diabetes Market Challenges

8.4 Type 2 Diabetes Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Type 2 Diabetes Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Type 2 Diabetes Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Type 2 Diabetes Market Competitive Situation by Manufacturers in 2024

Table 4. Global Type 2 Diabetes Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Type 2 Diabetes Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Type 2 Diabetes Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Type 2 Diabetes Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Type 2 Diabetes Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Type 2 Diabetes, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Type 2 Diabetes, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Type 2 Diabetes, Product Type & Application

Table 12. Global Key Manufacturers of Type 2 Diabetes, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Type 2 Diabetes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Type 2 Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Type 2 Diabetes Sales by Region (2020-2025) & (K Units)

Table 18. Global Type 2 Diabetes Sales Market Share by Region (2020-2025)

Table 19. Global Type 2 Diabetes Sales by Region (2026-2031) & (K Units)

Table 20. Global Type 2 Diabetes Sales Market Share by Region (2026-2031)

Table 21. Global Type 2 Diabetes Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Type 2 Diabetes Revenue Market Share by Region (2020-2025)

Table 23. Global Type 2 Diabetes Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Type 2 Diabetes Revenue Market Share by Region (2026-2031)

Table 25. North America Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Type 2 Diabetes Sales by Country (2020-2025) & (K Units)

Table 27. North America Type 2 Diabetes Sales by Country (2026-2031) & (K Units)

Table 28. North America Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Type 2 Diabetes Sales by Country (2020-2025) & (K Units)

Table 32. Europe Type 2 Diabetes Sales by Country (2026-2031) & (K Units)

Table 33. Europe Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Type 2 Diabetes Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Type 2 Diabetes Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Type 2 Diabetes Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Type 2 Diabetes Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Type 2 Diabetes Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Type 2 Diabetes Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Type 2 Diabetes Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Type 2 Diabetes Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Type 2 Diabetes Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Type 2 Diabetes Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Type 2 Diabetes Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Type 2 Diabetes Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Type 2 Diabetes Sales (K Units) by Type (2020-2025)

Table 51. Global Type 2 Diabetes Sales (K Units) by Type (2026-2031)

Table 52. Global Type 2 Diabetes Sales Market Share by Type (2020-2025)

Table 53. Global Type 2 Diabetes Sales Market Share by Type (2026-2031)

Table 54. Global Type 2 Diabetes Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Type 2 Diabetes Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Type 2 Diabetes Revenue Market Share by Type (2020-2025)

Table 57. Global Type 2 Diabetes Revenue Market Share by Type (2026-2031)

Table 58. Global Type 2 Diabetes Price (USD/Unit) by Type (2020-2025)

Table 59. Global Type 2 Diabetes Price (USD/Unit) by Type (2026-2031)

Table 60. Global Type 2 Diabetes Sales (K Units) by Application (2020-2025)

Table 61. Global Type 2 Diabetes Sales (K Units) by Application (2026-2031)

Table 62. Global Type 2 Diabetes Sales Market Share by Application (2020-2025)

Table 63. Global Type 2 Diabetes Sales Market Share by Application (2026-2031)

Table 64. Global Type 2 Diabetes Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Type 2 Diabetes Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Type 2 Diabetes Revenue Market Share by Application (2020-2025)

Table 67. Global Type 2 Diabetes Revenue Market Share by Application (2026-2031)

Table 68. Global Type 2 Diabetes Price (USD/Unit) by Application (2020-2025)

Table 69. Global Type 2 Diabetes Price (USD/Unit) by Application (2026-2031)

Table 70. Novo Nordisk Company Information

Table 71. Novo Nordisk Description and Business Overview

Table 72. Novo Nordisk Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Novo Nordisk Type 2 Diabetes Product

Table 74. Novo Nordisk Recent Developments/Updates

Table 75. Sanofi Company Information

Table 76. Sanofi Description and Business Overview

Table 77. Sanofi Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Sanofi Type 2 Diabetes Product

Table 79. Sanofi Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Merck Type 2 Diabetes Product

Table 84. Merck Recent Developments/Updates

Table 85. Eli Lily Company Information

Table 86. Eli Lily Description and Business Overview

Table 87. Eli Lily Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Eli Lily Type 2 Diabetes Product

Table 89. Eli Lily Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. AstraZeneca Type 2 Diabetes Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Astellas Pharma Company Information

Table 96. Astellas Pharma Description and Business Overview

Table 97. Astellas Pharma Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Astellas Pharma Type 2 Diabetes Product

Table 99. Astellas Pharma Recent Developments/Updates

Table 100. Daiichi Sankyo Company Information

Table 101. Daiichi Sankyo Description and Business Overview

Table 102. Daiichi Sankyo Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Daiichi Sankyo Type 2 Diabetes Product

Table 104. Daiichi Sankyo Recent Developments/Updates

Table 105. Biocon Company Information

Table 106. Biocon Description and Business Overview

Table 107. Biocon Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Biocon Type 2 Diabetes Product

Table 109. Biocon Recent Developments/Updates

Table 110. Boehringer Ingelheim Company Information

Table 111. Boehringer Ingelheim Description and Business Overview

Table 112. Boehringer Ingelheim Type 2 Diabetes Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Boehringer Ingelheim Type 2 Diabetes Product

Table 114. Boehringer Ingelheim Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Type 2 Diabetes Distributors List

Table 118. Type 2 Diabetes Customers List

Table 119. Type 2 Diabetes Market Trends

Table 120. Type 2 Diabetes Market Drivers

Table 121. Type 2 Diabetes Market Challenges

Table 122. Type 2 Diabetes Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Type 2 Diabetes

Figure 2. Global Type 2 Diabetes Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Type 2 Diabetes Market Share by Type: 2024 & 2031

Figure 4. Insulins Product Picture

Figure 5. DPP-4 Inhibitors Product Picture

Figure 6. GLP-1 Receptor Agonists Product Picture

Figure 7. SGLT-2 Inhibitors Product Picture

Figure 8. Global Type 2 Diabetes Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Type 2 Diabetes Market Share by Application: 2024 & 2031

Figure 10. Drugstore

Figure 11. Hospital

Figure 12. Others

Figure 13. Global Type 2 Diabetes Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Type 2 Diabetes Market Size (2020-2031) & (US$ Million)

Figure 15. Global Type 2 Diabetes Sales (2020-2031) & (K Units)

Figure 16. Global Type 2 Diabetes Average Price (USD/Unit) & (2020-2031)

Figure 17. Type 2 Diabetes Report Years Considered

Figure 18. Type 2 Diabetes Sales Share by Manufacturers in 2024

Figure 19. Global Type 2 Diabetes Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Type 2 Diabetes Players: Market Share by Revenue in Type 2 Diabetes in 2024

Figure 21. Type 2 Diabetes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Type 2 Diabetes Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Type 2 Diabetes Sales Market Share by Country (2020-2031)

Figure 24. North America Type 2 Diabetes Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Type 2 Diabetes Sales Market Share by Country (2020-2031)

Figure 28. Europe Type 2 Diabetes Revenue Market Share by Country (2020-2031)

Figure 29. Germany Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Type 2 Diabetes Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Type 2 Diabetes Revenue Market Share by Region (2020-2031)

Figure 36. China Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Type 2 Diabetes Sales Market Share by Country (2020-2031)

Figure 47. Latin America Type 2 Diabetes Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Type 2 Diabetes Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Type 2 Diabetes Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Type 2 Diabetes Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Type 2 Diabetes by Type (2020-2031)

Figure 57. Global Revenue Market Share of Type 2 Diabetes by Type (2020-2031)

Figure 58. Global Type 2 Diabetes Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Type 2 Diabetes by Application (2020-2031)

Figure 60. Global Revenue Market Share of Type 2 Diabetes by Application (2020-2031)

Figure 61. Global Type 2 Diabetes Price (USD/Unit) by Application (2020-2031)

Figure 62. Type 2 Diabetes Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions